AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Mar 15, 2024 | Sale | $6.00 | 50,000 | 300,000 | 984,476 | Mar 19, 2024, 02:30 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Mar 08, 2024 | Sale | $5.19 | 25,000 | 129,685 | 1,040,371 | Mar 12, 2024, 01:45 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Mar 09, 2024 | Option Exercise | $4.88 | 5,895 | 28,768 | 1,034,476 | Mar 12, 2024, 01:45 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Jun 08, 2022 | Buy | $0.96 | 45,871 | 44,036 | 882,871 | Jun 10, 2022, 05:26 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Feb 09, 2021 | Sale | $6.75 | 11,540 | 77,895 | 860,460 | Feb 10, 2021, 08:17 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Feb 10, 2021 | Sale | $6.75 | 23,460 | 158,355 | 837,000 | Feb 10, 2021, 08:17 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Feb 08, 2021 | Sale | $6.50 | 40,792 | 265,148 | 872,000 | Feb 09, 2021, 04:00 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Jun 30, 2020 | Option Exercise | $4.86 | 94 | 457 | 912,792 | Jul 02, 2020, 12:00 AM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | May 31, 2020 | Option Exercise | $4.87 | 4,132 | 20,123 | 912,553 | Jun 02, 2020, 05:14 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | May 08, 2020 | Sale | $5.00 | 40,000 | 200,000 | 902,113 | May 11, 2020, 04:15 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Apr 14, 2020 | Sale | $3.70 | 40,000 | 148,000 | 982,113 | May 04, 2020, 04:05 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Apr 27, 2020 | Sale | $4.00 | 40,000 | 160,000 | 942,113 | May 04, 2020, 04:05 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Apr 29, 2020 | Sale | $4.50 | 40,000 | 180,000 | 1,022,113 | May 01, 2020, 04:05 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Mar 31, 2020 | Option Exercise | $2.19 | 97 | 212 | 1,062,113 | Apr 02, 2020, 04:16 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Feb 29, 2020 | Option Exercise | $3.73 | 5,066 | 18,896 | 1,061,881 | Mar 03, 2020, 07:38 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Dec 31, 2019 | Option Exercise | $5.82 | 147 | 856 | 1,052,375 | Feb 26, 2020, 04:20 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Nov 30, 2019 | Option Exercise | $7.79 | 6,544 | 50,978 | 1,052,193 | Feb 26, 2020, 04:05 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Dec 31, 2019 | Option Exercise | $5.82 | 329 | 1,915 | 1,044,165 | Jan 02, 2020, 04:15 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Nov 30, 2019 | Option Exercise | $7.79 | 14,572 | 113,516 | 1,044,165 | Dec 02, 2019, 04:56 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sep 30, 2019 | Option Exercise | $3.18 | 145 | 461 | 1,044,165 | Oct 02, 2019, 04:33 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Aug 31, 2019 | Option Exercise | $3.80 | 6,460 | 24,548 | 1,043,981 | Sep 03, 2019, 06:09 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Jun 30, 2019 | Option Exercise | $4.20 | 149 | 626 | 1,035,869 | Jul 02, 2019, 12:00 AM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | May 31, 2019 | Option Exercise | $3.72 | 6,591 | 24,519 | 1,035,689 | Jun 03, 2019, 04:15 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Mar 31, 2019 | Option Exercise | $6.91 | 263 | 1,817 | 1,027,708 | Apr 01, 2019, 04:40 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Feb 28, 2019 | Option Exercise | $8.05 | 6,721 | 54,104 | 1,027,642 | Mar 01, 2019, 05:23 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Dec 31, 2018 | Option Exercise | $6.30 | 162 | 1,021 | 1,019,791 | Jan 03, 2019, 05:30 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Dec 10, 2018 | Buy | $7.78 | 1,000 | 7,780 | 1,019,624 | Dec 11, 2018, 05:41 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Dec 06, 2018 | Buy | $8.69 | 2,000 | 17,380 | 1,018,624 | Dec 10, 2018, 05:47 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Nov 30, 2018 | Option Exercise | $8.59 | 7,177 | 61,650 | 1,016,624 | Dec 04, 2018, 04:05 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Nov 21, 2018 | Buy | $10.25 | 1,000 | 10,250 | 1,009,229 | Nov 26, 2018, 01:43 PM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sep 30, 2018 | Option Exercise | $17.51 | 162 | 2,837 | 1,008,229 | Oct 02, 2018, 12:00 AM |
AQST | | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | Aug 31, 2018 | Option Exercise | $18.01 | 6,510 | 117,245 | 1,008,062 | Sep 05, 2018, 05:39 PM |